Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MFSD4 Inhibitors

MFSD4 inhibitors represent a unique class of compounds that indirectly influence the functionality of MFSD4, a protein categorized within the Major Facilitator Superfamily (MFS) of transporters. These inhibitors do not directly target the MFSD4 protein. Instead, they focus on modulating the cellular environment, which is essential for the optimal operation of MFSD4. The primary role of MFSD4 in cellular processes, while not fully elucidated, is believed to involve the transport of various substrates across cell membranes, a characteristic function of MFS transporters. The mechanism of action of MFSD4 inhibitors is rooted in altering crucial factors such as ion gradients and membrane potentials, which are significant driving forces for the transport activity of MFSD4. By influencing these parameters, the inhibitors can indirectly affect the transport efficiency and capacity of MFSD4. For instance, modifying the sodium or potassium ion concentration gradients across the membrane can change the electrochemical potential, impacting the functionality of MFSD4 as a transporter. Furthermore, some compounds in this class target processes involved in protein trafficking and synthesis. Such inhibitors can indirectly influence the localization and availability of MFSD4 on the cell membrane, where it performs its transport functions. Disruptions in protein trafficking pathways could lead to changes in MFSD4 distribution, affecting its operational efficiency. In essence, MFSD4 inhibitors are antagonists of the MFSD4 protein but rather influence the broader cellular context that dictates MFSD4's transporter activity. This approach highlights the intricate interplay between membrane transporters and their cellular environment, offering insights into how altering certain cellular conditions can indirectly modulate transporter functions. The diverse mechanisms through which these inhibitors operate reflect the complexity of targeting proteins involved in essential cellular processes and underscore the nuanced understanding required to influence such proteins' activity.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ouabain-d3 (Major)

sc-478417
1 mg
$506.00
(0)

Ouabain inhibits the Na⁺/K⁺-ATPase pump, potentially altering ion gradients and indirectly affecting MFSD4's transporter activity.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A disrupts Golgi apparatus function, which might indirectly affect the trafficking and surface expression of MFSD4.

Furosemide

54-31-9sc-203961
50 mg
$40.00
(1)

Furosemide inhibits the Na⁺-K⁺-2Cl⁻ cotransporter, potentially altering ion balance and indirectly influencing MFSD4.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$58.00
$170.00
15
(1)

Nifedipine, another calcium channel blocker, could indirectly affect calcium-dependent processes, potentially influencing MFSD4.

12β-Hydroxydigitoxin

20830-75-5sc-213604
sc-213604A
1 g
5 g
$140.00
$680.00
(0)

12β-Hydroxydigitoxin inhibits Na⁺/K⁺-ATPase, potentially affecting ion gradients and membrane potential, which could indirectly impact MFSD4.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

Monensin, as an ionophore, might alter intracellular ion concentrations, indirectly affecting MFSD4's transport activity.

Amiloride • HCl

2016-88-8sc-3578
sc-3578A
25 mg
100 mg
$22.00
$56.00
6
(2)

Amiloride inhibits epithelial sodium channels, potentially altering membrane potential and indirectly impacting MFSD4.

Valinomycin

2001-95-8sc-200991
25 mg
$163.00
3
(1)

Valinomycin, a potassium ionophore, could change potassium gradients, potentially affecting MFSD4's function.

Ivermectin

70288-86-7sc-203609
sc-203609A
100 mg
1 g
$56.00
$75.00
2
(2)

Ivermectin modulates chloride channels, which might indirectly influence the cellular environment affecting MFSD4.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide inhibits protein synthesis, potentially affecting the production and turnover of proteins like MFSD4.